Why the study?
A standardized approach for clinical evaluation of early vascular aging in youth remains elusive, leaving gaps in understanding optimal methodology.
This expert consensus document provides an updated overview of methods to measure early vascular aging in youth and addresses challenges in clinical translation.
Answers are grounded in this paper and cite their sources.
Informs youth vascular assessment strategies; extends consensus methods while leaving clinical translation open pending further validation.
Since the conceptualization of early vascular aging (EVA) in 2008, significant efforts have been made to develop and improve its assessment. Initially lead by the investigation of arterial stiffness through pulse wave velocity (PWV), several additional vascular aging biomarkers have gained prominence in recent years. Despite expanding literature addressing methodological concerns associated with these biomarkers in youth, a standardized approach for clinical evaluation of EVA remains elusive, leaving pertinent gaps in understanding the optimal methodology. This article, resulting from international consensus efforts from the Youth Vascular Consortium, aims to provide an updated overview of methods available to measure EVA in youth and to discuss challenges in translating these methods into clinical practice.
No takes yet. Share an insight, caveat, or question.
Hersant et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: